Heparin and its low molecular weight derivatives: anticoagulant and antithrombotic properties

Haemostasis
E HolmerU Lindahl

Abstract

The anticoagulant and antithrombotic effect of heparin has been known for many decades. Nevertheless, the knowledge of structure-activity relationships and its mechanisms of action has been rather limited. However, in recent years important progress has been made and our understanding of how heparin works has increased significantly. Based on this information, attempts have been made to modify heparin to get improved pharmacological properties. The present communication summarizes the recent development. It is shown that certain heparin derivatives of low molecular weight are highly interesting compounds from a clinical point of view. Biochemical and pharmacological properties of such a preparation named Fragmin are presented.

Citations

Sep 1, 1990·World Journal of Surgery·V V Kakkar, M D Stringer
Sep 1, 1993·Journal of the American College of Cardiology·A A QuyyumiS E Epstein
Dec 12, 2001·Alimentary Pharmacology & Therapeutics·Y LiC H Cho
Apr 25, 2000·Journal of Pediatric Hematology/oncology·R C PunzalanJ C Gill
Jan 15, 1992·European Journal of Biochemistry·F A OfosuM A Blajchman
Jan 1, 1997·Annual Review of Medicine·G F Pineo, R D Hull
Jun 15, 2006·Pathophysiology of Haemostasis and Thrombosis·Guareide CarelliLídia R de Carvalho
Feb 1, 1988·American Journal of Surgery·M O Perry
Mar 15, 1992·Thrombosis Research·S HamanoN Sakuragawa
May 20, 1999·Baillière's Clinical Haematology·G F Pineo, R D Hull
Jul 1, 1990·Baillière's Clinical Haematology·A S Gallus
Oct 5, 2001·Expert Opinion on Pharmacotherapy·G F Pineo, R D Hull
Apr 4, 2017·Biomolecules & Therapeutics·Joo Hee KimHye Sun Gwak
Feb 24, 2007·Journal of Biochemistry·Ryoichi SakiyamaToshikazu Nakamura
Jul 14, 2001·Arteriosclerosis, Thrombosis, and Vascular Biology·J HirshUNKNOWN American Heart Association

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.